Is Mistletoe Treatment Beneficial in Invasive Breast Cancer? A New Approach to an Unresolved Problem
![Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657) | Request PDF Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657) | Request PDF](https://i1.rgstatic.net/publication/317341463_Comparison_of_residual_cancer_burden_American_Joint_Committee_on_Cancer_staging_and_pathologic_complete_response_in_breast_cancer_after_neoadjuvant_chemotherapy_results_from_the_I-SPY_1_TRIAL_CALGB_15/links/5fbcf1e892851c933f527680/largepreview.png)
Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657) | Request PDF
![Results of chest wall reirradiation using pulsed-dose-rate (PDR) brachytherapy molds for breast cancer local recurrences - International Journal of Radiation Oncology, Biology, Physics Results of chest wall reirradiation using pulsed-dose-rate (PDR) brachytherapy molds for breast cancer local recurrences - International Journal of Radiation Oncology, Biology, Physics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/61448018-1eda-4499-a5c3-7d5565274f24/gr1_lrg.gif)